Your browser doesn't support javascript.
loading
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?
Morton, Molly; McLaughlin, Eric M; Calo, Corinne A; Lightfoot, Michelle; Bixel, Kristin L; Cohn, David E; Cosgrove, Casey M; Copeland, Larry J; O'Malley, David M; Nagel, Christa I; Chambers, Laura M.
Afiliación
  • Morton M; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, Starling Loving Hall, M210, 320 W. 10(th) Avenue, Columbus, OH 43210, USA. Electronic address: molly.morton@osumc.edu.
  • McLaughlin EM; Center for Biostatistics, The Ohio State University, Columbus, OH 43210, USA.
  • Calo CA; Division of Gynecologic Oncology, OhioHealth, Columbus, OH, USA.
  • Lightfoot M; Division of Gynecologic Oncology, New York University, New York, NY, USA.
  • Bixel KL; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, Starling Loving Hall, M210, 320 W. 10(th) Avenue, Columbus, OH 43210, USA.
  • Cohn DE; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, Starling Loving Hall, M210, 320 W. 10(th) Avenue, Columbus, OH 43210, USA.
  • Cosgrove CM; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, Starling Loving Hall, M210, 320 W. 10(th) Avenue, Columbus, OH 43210, USA.
  • Copeland LJ; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, Starling Loving Hall, M210, 320 W. 10(th) Avenue, Columbus, OH 43210, USA.
  • O'Malley DM; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, Starling Loving Hall, M210, 320 W. 10(th) Avenue, Columbus, OH 43210, USA.
  • Nagel CI; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, Starling Loving Hall, M210, 320 W. 10(th) Avenue, Columbus, OH 43210, USA.
  • Chambers LM; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, Starling Loving Hall, M210, 320 W. 10(th) Avenue, Columbus, OH 43210, USA.
Gynecol Oncol ; 177: 46-52, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37639902
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos